IBRX Stock Analysis: Buy, Sell, or Hold?
IBRX - ImmunityBio, Inc. Common Stock
$8.11
-0.04 (-0.49%)
▼
5d:
+4.51%
30d:
+4.24%
90d:
+22.51%
BUY
MODERATE Confidence
Analysis Updated: May 13, 2026 12:00 AM ET
Earnings: May 11, 2026
0d
Smart Money Accumulation
IBRX is down 4.4% this week, but smart money is accumulating calls. Top strike: $9 2026-07-17 with 13,267 OI. Call ratio: 80% View Scanner →
Strength: 9.5/10
Get Alerted When IBRX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
56 traders called IBRX this week
94% bullish • 6 bearish
94% bullish • 6 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: IBRX shows positive signals but monitor for confirmation. Market pricing in 27.0% decline. Moderate conviction.
💡 BUY OPPORTUNITY: IBRX shows positive signals but monitor for confirmation. Market pricing in 27.0% decline. Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: IBRX is currently trading at $8.11, which is considered extended relative to its 30-day fair value range of $7.13 to $8.11. From a valuation perspective, the stock is trading at a discount (Forward PE: 77.6) compared to its historical average (199.3). Remarkably, the market is currently pricing in an annual earnings decline of 27.0% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, IBRX is in a uptrend. Immediate support is located at $6.94, while resistance sits at $8.69.
Market Sentiment: IBRX has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $15.50 (+90.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, IBRX is in a uptrend. Immediate support is located at $6.94, while resistance sits at $8.69.
Market Sentiment: IBRX has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $15.50 (+90.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$7.13 -
$8.11
Company Quality Score
62/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
61.9%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 90.2% below Wall St target ($15.50)
Trading Range Analysis
30-Day Trading Range
$7.13 -
$8.11
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$6.94
Resistance Level
$8.69
Current Trend
Uptrend
Technical data as of
May 14, 2026
Fundamental Context
Forward P/E (Next Year Est.)
77.62
Wall Street Target
$15.50
(+90.2%)
Revenue Growth (YoY)
167.6%
Valuation Discount vs History
-27.0% cheaper
PE vs Historical
77.6 vs 199.3
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-27.0%
(market-implied from PE analysis)
1-Year Target
$7.33
(-10%)
2-Year Target
$6.60
(-19%)
3-Year Target
$5.94
(-27%)
3-Yr Target (if PE normalizes)
(PE: 78→199)
$15.26
(+87%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 77.6 to 199.3
Stabilization Target:
$20.93
(+156.8%)
PE Expansion Potential:
+156.8%
Share & Embed Analysis
Last updated: May 14, 2026 12:45 PM ET
Data refreshes hourly during market hours. Next update: 1:45 PM
Data refreshes hourly during market hours. Next update: 1:45 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is IBRX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
7
Sells
Net
INSIDERS SELLING
Recent Transactions
Barry J Simon
SELL
75000 shares
2026-02-24
Barry J Simon
SELL
165000 shares
2026-02-23
Christobel Selecky
SELL
25000 shares
2026-02-23
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$550 | 67 BUY |
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$57 | 59 HOLD |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$875 | 59 HOLD |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$53 | 61 BUY |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$79 | 58 HOLD |
Advanced IBRX Option Strategies
Professional options setups generated by AI based on today's IBRX price and gamma walls.
